If HLTH Europe 2025 was dominated by discussions around AI’s potential, HLTH Europe 2026 highlighted the industry’s shift toward execution. AI dominated the agenda at the event, and the discussions revealed a notable shift in how the healthcare industry is approaching AI. Unlike previous years, where conversations largely centered on AI’s potential and emerging use cases, this year’s discussions reflected a more mature market.
Across interactions with healthcare providers, health systems, policymakers, digital health innovators, technology vendors, and investors, the emphasis was no longer about whether AI belongs in healthcare. Instead, it focused on how AI can be operationalized responsibly, integrated into clinical and operational workflows, and deliver measurable value.
While each discussion reflected different priorities, several strategic themes consistently emerged. Collectively, these observations suggest that healthcare AI is entering a new phase—one characterized less by experimentation and more by enterprise adoption, governance, workflow integration, and demonstrable outcomes.
Healthcare AI Is Moving Beyond Innovation into Operationalization
One of the strongest messages throughout HLTH Europe was that AI is no longer viewed as an experimental technology. Instead, leading healthcare organizations are embedding AI into day-to-day clinical and operational workflows to address workforce shortages, administrative burden, and increasing demand for care.
This perspective was consistently reinforced across discussions with providers, health systems, and technology vendors. Representatives from Charité emphasized that AI adoption is no longer optional and described how the organization is building enterprise AI capabilities to support clinical, operational, and research functions. Similarly, Mayo Clinic highlighted the importance of centralized governance and enterprise data architectures that enable AI to move beyond isolated pilots into scalable clinical practice.
The same transition was evident among technology vendors. Companies such as Kore.ai, Tandem Health, and Ada Health described increasing demand for AI solutions that are embedded within provider workflows rather than operating as standalone applications. Whether applied to clinical documentation, care navigation, claims management, or administrative automation, the emphasis has shifted toward seamless integration and measurable operational improvements.
This transition marks an important inflection point for the healthcare AI market. Success will increasingly depend not on developing more AI applications, but on integrating them into existing healthcare workflows in ways that improve clinician productivity, patient outcomes, and organizational efficiency.
Governance Is Emerging as Healthcare AI’s New Competitive Differentiator
While discussions around AI capabilities continue to evolve rapidly, another theme surfaced just as consistently throughout the conference: trust. Across conversations with providers, policymakers, and technology vendors, governance is no longer viewed simply as a regulatory requirement—it is increasingly becoming a strategic enabler of AI adoption.
This perspective was particularly evident during discussions with representatives from the German Ministry of Health, who highlighted concerns around “shadow AI”—the growing use of unauthorized AI tools within healthcare settings. As clinicians gain easier access to general-purpose AI models, healthcare organizations face the challenge of balancing innovation with patient safety, privacy, and accountability. The message was clear: healthcare AI must operate within governed, clinically validated environments rather than as isolated productivity tools.
Technology vendors echoed similar priorities. Infermedica emphasized regulatory certification and clinical validation as key competitive differentiators, while Truviq focused on AI governance, orchestration, and enterprise oversight as healthcare organizations begin deploying multiple AI solutions across operational workflows. Interoperability discussions also reinforced that AI should increasingly be treated as another “user” of healthcare systems, requiring the same levels of governance, auditability, and accountability expected of human users.
Collectively, these discussions suggest that governance is evolving from a compliance function into a competitive capability. Vendors that can demonstrate trust, transparency, and responsible AI deployment are likely to be better positioned as healthcare organizations scale enterprise AI initiatives.
Data Is Becoming the Competitive Moat
If governance emerged as one pillar of healthcare AI maturity, data clearly emerged as another. While foundation models continue to improve rapidly, several discussions indicated that sustainable competitive advantage will increasingly depend on access to differentiated healthcare data rather than AI algorithms alone.
This was reflected across organizations with very different business models. Withings highlighted how more than a decade of longitudinal health and wellness data provides a foundation for expanding AI-driven patient engagement and chronic disease management. OWKIN discussed the growing importance of multimodal datasets in accelerating precision medicine and pharmaceutical research, while Data4Life reinforced the industry’s need for stronger health data ecosystems capable of supporting research and innovation at scale.
Several conversations also pointed toward a broader shift in thinking. Rather than asking which organization has the most advanced AI model, healthcare leaders are increasingly asking who owns the most relevant, highest-quality, and clinically meaningful data. As AI capabilities become more accessible, proprietary datasets, real-world evidence, and patient-generated information may become the primary sources of long-term differentiation.
For healthcare technology vendors, this reinforces the importance of investing not only in AI capabilities but also in robust data strategies that support continuous learning, personalization, and clinical relevance.
ROI Has Become the Universal Language of Healthcare AI
Perhaps the most consistent message across vendors, providers, and health systems was the growing emphasis on measurable outcomes. Discussions that once focused primarily on innovation and technical capabilities are increasingly centered on operational impact, financial value, and clinical improvement.
Kore.ai captured this shift succinctly by noting that conversations around AI are now increasingly about return on investment (ROI). Similar perspectives emerged across discussions involving AI-powered documentation, revenue cycle management, patient engagement, and preventive care. Whether reducing clinician administrative burden, improving coding accuracy, enhancing patient navigation, or enabling earlier interventions, organizations are increasingly expected to demonstrate tangible value rather than simply showcase technological sophistication.
Health systems reinforced this perspective from the buyer’s side. Speakers from Charité and Mayo Clinic emphasized that ROI extends beyond financial savings alone. Improvements in patient outcomes, clinician productivity, diagnostic efficiency, prevention, and overall quality of care are becoming equally important measures of success.
This marks a significant evolution in the healthcare AI market. Winning solutions will not necessarily be those with the most advanced algorithms, but those capable of delivering measurable clinical, operational, and economic outcomes within existing healthcare workflows.
Human with AI, Not Human vs. AI
One of the most thought-provoking sessions at HLTH Europe was the Oxford-style debate exploring whether Big Tech could ultimately deliver better healthcare than hospitals. While the discussion presented compelling arguments on both sides, it also highlighted a broader realization emerging across the industry.
Proponents argued that technology companies possess the scale, data, and digital capabilities needed to transform patient experiences, improve accessibility, and personalize care. Opposing viewpoints emphasized the irreplaceable role of clinicians in delivering empathy, exercising judgment, managing complexity, and maintaining accountability for patient outcomes.
Interestingly, while the audience ultimately voted in favor of hospitals, the debate itself reinforced that healthcare’s future is unlikely to be defined by one replacing the other. Instead, the strongest consensus emerging throughout the conference pointed toward collaboration— where AI augments clinical expertise rather than replacing it.
This perspective was consistently reflected across discussions with providers, technology companies, and health systems. Organizations are increasingly designing AI solutions that reduce administrative burden, enhance clinical decision-making, and improve workflow efficiency, while keeping clinicians firmly at the center of patient care.
Ultimately, the most successful healthcare AI strategies are unlikely to be those that seek to automate clinicians out of the process, but those that enable clinicians to deliver safer, more efficient, and more personalized care.
Implications for the Healthcare Technology Industry
Rather than revealing a breakthrough technology or a single defining innovation, HLTH Europe 2026 highlighted a broader market transition, with several strategic implications for the healthcare industry:
- For healthcare technology companies, competitive advantage will increasingly depend on embedding AI into clinical and operational workflows rather than introducing standalone point solutions.
- Governance, clinical validation, interoperability, and transparency are emerging as strategic differentiators as AI adoption scales.
- Proprietary healthcare data and the ability to demonstrate tangible clinical, operational, and financial value will increasingly separate market leaders from followers.
- The most successful AI strategies will augment clinical expertise, improve patient experiences, and strengthen—rather than replace—the human element of care.
Ready to Lead the Transformation?
- Book a Growth Strategy Session: Align your growth roadmap with Frost & Sullivan’s visionary Growth Pipeline™ Dialog.
- Engage with Growth Experts: Co-design AI-enabled, data-driven operating models that scale industry-specific and commercial impact.
- Share Your Transformation Story: Position your organization as a transformation leader through Frost & Sullivan’s Transformational Growth Leadership platform.
- Join the Growth Council: Collaborate with industry leaders shaping the future of your ecosystem.
- Nominate for the Best Practices Recognition: Be recognized for excellence in growth strategy, execution, and customer impact.
- Demonstrate Industry Positioning on the Frost Radar™: Benchmark your growth performance and innovation strength against industry competitors.
- Accelerate Brand & Demand Growth: Accelerate awareness, engagement, and revenue growth through integrated brand and demand generation strategies.
Annexure: Key Actions Advancing the Future of Digital Health
The strategic priorities highlighted at HLTH Europe 2026 align with broader efforts across the healthcare ecosystem to improve care delivery, enhance operational efficiency, strengthen data interoperability, and create measurable value. The following analyses provide deeper actionable intelligence on the forces shaping healthcare transformation:
